Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 271–285 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3831 SLC34A1 Gene Fanconi Renotubular Syndrome Type 2 Genetic Test This test identifies pathogenic mutations in the SLC34A1 gene, confirming a diagnosis of Fanconi renotubular syndrome type 2.	Peripheral whole blood (3-5 mL in EDTA tube), extracted DNA, or FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLC34A1 gene sequence", "Copy number variants in SLC34A1"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "> 99.9%"}, {"name": "Analytical Specificity", "reference_range": "> 99.9%"}] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Suspected Fanconi renotubular syndrome type 2", "Family history of FRTS2", "Need for genetic confirmation for clinical management and counselling"] Measurement technique Confirm with laboratory Codes LOINC: 81322-0 ICD-10: N15.1 Clinical summary This test identifies pathogenic mutations in the SLC34A1 gene, confirming a diagnosis of Fanconi renotubular syndrome type 2.
TEST-4475 SLC35A1 Gene (CDG IIF) Next‑Generation Sequencing Genetic Test This test detects pathogenic variants in the SLC35A1 gene associated with Congenital Disorder of Glycosylation Type IIF (CDG IIF).	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC35A1 gene", "Coding region and intronic boundaries of the SLC35A1 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Clinical suspicion of Congenital Disorder of Glycosylation Type IIF (CDG IIF)", "Confirmation of diagnosis in individuals with relevant clinical features"] Measurement technique Confirm with laboratory Codes LOINC: 79231-5 ICD-10: E77.8 Clinical summary This test detects pathogenic variants in the SLC35A1 gene associated with Congenital Disorder of Glycosylation Type IIF (CDG IIF).
TEST-2352 SLC35D1 Gene Sequencing for Schneckenbecken Dysplasia (NGS) Test This test analyzes the SLC35D1 gene to detect mutations associated with Schneckenbecken dysplasia.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLC35D1 gene mutations", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your physician.", "Withhold heparin-containing anticoagulants 24 hours prior to blood draw."] Indications ["Suspected Schneckenbecken dysplasia", "Prenatal diagnosis", "Genetic counseling for families with affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 103304-4 ICD-10: Q77.8 Clinical summary This test analyzes the SLC35D1 gene to detect mutations associated with Schneckenbecken dysplasia.
TEST-5216 SLC5A7 Gene Analysis (Congenital Myasthenic Syndrome Type 20, Presynaptic) Test This genetic test identifies pathogenic variants in the SLC5A7 gene associated with Presynaptic Congenital Myasthenic Syndrome Type 20.	Whole blood (3–5 mL in EDTA tube), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC5A7 gene", "Copy Number Variations (CNVs) in SLC5A7"] Parameters [] Preparation ["No specific fasting required", "No medication modification needed unless advised by consultant"] Indications ["Suspected Presynaptic Congenital Myasthenic Syndrome Type 20", "Neonates or early childhood presentation with neuromuscular symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 81328-4 ICD-10: G70.2 Clinical summary This genetic test identifies pathogenic variants in the SLC5A7 gene associated with Presynaptic Congenital Myasthenic Syndrome Type 20.
TEST-4158 SLC6A8 Gene (Creatine Deficiency Syndrome, X‑Linked) Genetic Test This genetic test evaluates the SLC6A8 gene for mutations causing X-linked creatine deficiency syndrome.	Whole Blood (venous) or Finger‑Prick Dried Blood Spot on FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC6A8 gene", "Point mutations", "Insertions", "Deletions", "Copy-number variants (CNV)"] Parameters [] Preparation [] Indications ["Suspected X-linked creatine deficiency syndrome", "Neurometabolic disorder investigation"] Measurement technique Confirm with laboratory Codes LOINC: 91872-3 ICD-10: E72.8 Clinical summary This genetic test evaluates the SLC6A8 gene for mutations causing X-linked creatine deficiency syndrome.
TEST-2030 SMAD4 Gene Test (Juvenile Polyposis & HHT) NGS DNA Sequencing This test identifies pathogenic variants in the SMAD4 gene associated with Juvenile Polyposis Syndrome (JPS) and Hereditary Hemorrhagic Telangiectasia (HHT).	Peripheral Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline pathogenic variants in the SMAD4 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions or chemotherapy"] Indications ["Individuals with clinical features suggestive of JPS or HHT", "Family history of JPS or HHT", "Pre-symptomatic testing in at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 21645-8 ICD-10: K63.5, I78.0 Clinical summary This test identifies pathogenic variants in the SMAD4 gene associated with Juvenile Polyposis Syndrome (JPS) and Hereditary Hemorrhagic Telangiectasia (HHT).
TEST-5477 SMARCAD1 Gene Adermatoglyphia Genetic Test This test identifies pathogenic or likely pathogenic variants in the SMARCAD1 gene associated with autosomal dominant adermatoglyphia.	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SMARCAD1 gene", "Single nucleotide variants", "Small insertions", "Small deletions"] Parameters [] Preparation ["A comprehensive clinical history must be submitted.", "A mandatory pre-test genetic counselling session is required.", "No fasting is required.", "Obtain clearance from treating physician if on anticoagulant therapy."] Indications ["Suspected diagnosis of autosomal dominant adermatoglyphia", "Family history of adermatoglyphia", "Need for definitive genetic confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 81335-5 ICD-10: Q84.8 Clinical summary This test identifies pathogenic or likely pathogenic variants in the SMARCAD1 gene associated with autosomal dominant adermatoglyphia.
TEST-2948 SMARCE1 Gene Genetic Test for Coffin-Siris Syndrome This diagnostic test evaluates the SMARCE1 gene for pathogenic variants associated with Coffin-Siris syndrome and meningioma predisposition.	Peripheral whole blood (FTA card or EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMARCE1 gene sequence", "Copy Number Variations (CNVs) in SMARCE1"] Parameters [] Preparation ["Do not discontinue prescribed medications without consulting your physician", "Inform the phlebotomist if on anticoagulants"] Indications ["Clinical suspicion of Coffin-Siris syndrome", "Family history of Coffin-Siris syndrome", "Evaluation for hereditary predisposition to clear cell meningiomas"] Measurement technique Confirm with laboratory Codes LOINC: 92709-6 ICD-10: Q87.1, Q85.8 Clinical summary This diagnostic test evaluates the SMARCE1 gene for pathogenic variants associated with Coffin-Siris syndrome and meningioma predisposition.
TEST-5258 SMC1A Gene Cornelia de Lange Syndrome Type 2 Genetic Test This test detects pathogenic variants in the SMC1A gene, confirming a diagnosis of Cornelia de Lange syndrome type 2.	Peripheral blood, dried blood spot, or extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SMC1A gene"] Parameters [] Preparation ["No special fasting or preparation is required for blood collection.", "For dried blood spots, a trained phlebotomist ensures proper sample quality."] Indications ["Suspected Cornelia de Lange syndrome type 2", "Confirmation of diagnosis", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 94297-1 ICD-10: Q87.1 Clinical summary This test detects pathogenic variants in the SMC1A gene, confirming a diagnosis of Cornelia de Lange syndrome type 2.
TEST-4703 SNX10 Gene Osteopetrosis of Infancy, Malignant Genetic Test This test detects pathogenic variants in the SNX10 gene associated with malignant infantile osteopetrosis.	Whole blood (EDTA), FTA card, or extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SNX10 gene", "Coding region and flanking intronic boundaries of SNX10"] Parameters [] Preparation ["No fasting required", "No dietary changes required", "No medication adjustments required"] Indications ["Infants presenting with features of malignant osteopetrosis", "Familial screening for SNX10-related osteopetrosis"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: Q78.2 Clinical summary This test detects pathogenic variants in the SNX10 gene associated with malignant infantile osteopetrosis.
TEST-4024 SNX14-Related Cerebellar Ataxia Genetic Test This test identifies pathogenic variants in the SNX14 gene associated with autosomal recessive spinocerebellar ataxia type 20 (SCAR20).	Peripheral Whole Blood (3–5 mL in EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SNX14 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["Attend a genetic counseling session", "No prolonged fasting required"] Indications ["Suspected autosomal recessive spinocerebellar ataxia type 20 (SCAR20)", "Family history of cerebellar ataxia"] Measurement technique Confirm with laboratory Codes LOINC: 81248-8 ICD-10: G11.9, G11.1 Clinical summary This test identifies pathogenic variants in the SNX14 gene associated with autosomal recessive spinocerebellar ataxia type 20 (SCAR20).
TEST-4038 SOAT1 Gene Atherosclerosis Genetic Test This test evaluates the SOAT1 gene for variants associated with an increased risk of early-onset atherosclerosis.	Whole blood, extracted DNA, or FTA card blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SOAT1 gene variants", "Inherited risk for atherosclerosis"] Parameters [] Preparation [] Indications ["Assessment of inherited risk for early-onset atherosclerosis", "Personalized cardiovascular risk management"] Measurement technique Confirm with laboratory Codes LOINC: 21636-3 ICD-10: I70.90 Clinical summary This test evaluates the SOAT1 gene for variants associated with an increased risk of early-onset atherosclerosis.
TEST-4898 SOBP Gene Intellectual Disability, Anterior Maxillary Protrusion & Strabismus NGS Test This test identifies genetic variants in the SOBP gene associated with intellectual disability, anterior maxillary protrusion, and strabismus.	Whole blood (EDTA), extracted genomic DNA, dried FTA card	3–4 weeks (21–28 business days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SOBP gene variants", "Single-nucleotide variants", "Small insertions/deletions", "Splicing variants"] Parameters [] Preparation ["No specific preparation required", "Provide a detailed three-generation family pedigree"] Indications ["Patients presenting with the syndromic triad of intellectual disability, anterior maxillary protrusion, and strabismus"] Measurement technique Confirm with laboratory Codes LOINC: 91606-7 ICD-10: F70.9, Q87.8 Clinical summary This test identifies genetic variants in the SOBP gene associated with intellectual disability, anterior maxillary protrusion, and strabismus.
TEST-5460 SOX10 Gene Genetic Test for Peripheral Demyelinating Neuropathy, Waardenburg Syndrome & Hirschsprung Disease This test evaluates the SOX10 gene for pathogenic variants associated with peripheral demyelinating neuropathy, Waardenburg syndrome type IV, and Hirschsprung disease.	Peripheral whole blood (3 mL EDTA), extracted DNA (≥2 µg), or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SOX10 gene sequence", "Pathogenic variants (SNVs, indels, splice-site variants, copy number variations)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected peripheral demyelinating neuropathy", "Suspected Waardenburg syndrome type IV", "Suspected Hirschsprung disease", "Family history of SOX10-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 93466-1 ICD-10: G60.0, Q87.8, Q43.1 Clinical summary This test evaluates the SOX10 gene for pathogenic variants associated with peripheral demyelinating neuropathy, Waardenburg syndrome type IV, and Hirschsprung disease.
TEST-4473 SOX10 Gene Waardenburg Syndrome Type 4C Genetic Test This test analyzes the SOX10 gene for mutations associated with Waardenburg syndrome type 4C.	Peripheral Whole Blood (EDTA tube) or Buccal Swab	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SOX10 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["Informed Consent Required", "Consult physician if on anticoagulants"] Indications ["Clinical suspicion of Waardenburg syndrome type 4C", "Familial risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 94850-3 ICD-10: Q87.89 Clinical summary This test analyzes the SOX10 gene for mutations associated with Waardenburg syndrome type 4C.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.